Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity. [electronic resource]

By: Contributor(s): Producer: 20130214Description: 6144-53 p. digitalISSN:
  • 1464-3391
Subject(s): Online resources: In: Bioorganic & medicinal chemistry vol. 20
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.